期刊文献+

缬沙坦联合卡维地洛治疗慢性心力衰竭的临床疗效观察 被引量:4

Observation of Clinical Efficacy of Valsartan Combined with Carvedilol on Chronic Heart Failure
下载PDF
导出
摘要 目的探讨缬沙坦联合卡维地洛治疗慢性心力衰竭的临床疗效。方法选择我院2007年5月至2009年9月慢性心力衰竭患者112例,随机分为2组,观察组和对照组。对照组患者采用常规治疗,如低盐饮食、给予洋地黄强心、利尿剂等,患者有心绞痛的给予硝酸酯类药物,观察组在对照组用药基础上,给予缬沙坦和卡维地洛。2组患者疗程为2个月。结果 2组患者治疗后,总有效率比较,差异有统计学意义,P<0.05。结论缬沙坦联合卡维地洛治疗慢性心力衰竭临床治疗效果显著,值得借鉴。 Objective To explore the clinical efficacy of valsartan combined with carvedilol on chronic heart failure.Methods 112 cases with chronic heart failure were selected from May 2007 to September 2009,and were randomly diviede into two groups, observation and control group.the routine therapy was used to control group,for example,low salt diet、digitalis treatment、diuretic, and drugs belonging to ester nitrate if the patients had angina pectoris,on the base of the therapy of the control group,valsartan combined with carvedilol was given to observation group.the course of the treatment in two groups was two months.Results After treatment,the total rate of clinical efficacy in observation group compared with that in control group,there was statistical difference, P 〈0.05.Conclusion Valsartan combined with carvedilol on chronic heart failure has significantly clinical efficacy,and the therapy should be the reference for doctors.
作者 殷淑娟
出处 《中外医疗》 2010年第33期1-2,共2页 China & Foreign Medical Treatment
关键词 慢性心力衰竭 缬沙坦 卡维地洛 Chronic heart failure Valsartan Carvedilol
  • 相关文献

参考文献4

二级参考文献19

  • 1吕卓人,梁磊,艾文婷.血管紧张素Ⅱ1型受体拮抗剂研究进展[J].中华心血管病杂志,2004,32(11):1054-1056. 被引量:61
  • 2罗杰.血管紧张素Ⅱ在人阻力动脉生成的双重途径:血管紧张素Ⅱ受体拮抗剂和转换酶抑制剂的治疗[J].国外医学.心血管疾病分册,2001,28(1):46-47.
  • 3[4]Verza M,Ammendola S,Gambardella A,et al.Regression of left ventricular hypertrophy in hypertensive elderly patients with carvedilol[J].J Arch Gerontol Geriatr,1996,47:S143-147.
  • 4[5]Hansson L,Anders H.Carvedilol in the treatment of hypertension-A review of the clinical data base[J].Scan Cardiovasc J,1998,47:S67-80.
  • 5[6]Jacob S,Rett K,Wicklmay M,et al.Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity:the carvedilol-metoprolol study[J].J Hypertens,1966,14:489-494.
  • 6[7]Cooke ED,Maltz MB,Smith RE,et al.Peripheral vascular effects of β-adrenoceptor blockade:comparison of two agents[J].Br J Clin Pharmcol,1987,24:359-366.
  • 7[8]Schofl C,Becker C,Prank K,et al.Twenty-four-hour rhythms of plasma eatecholamines and their relation to cardiovascular parameterse in healthy young men[J].Eur J Endocrinol,1997,137:199-211.
  • 8Cohn JN,Tognoni G. A randomized trial of the angiotensin receptor blocker valsartan in chronic heart failure [J]. N Engl J Med, 2001,345;667 - 675.
  • 9Pfeffer MA,Swedberg K,Granger CB,et al. Effects of candesartan on mortaliy and morbidity in patients with heart failure the CHARM - overall pregramme[J]. Lancet, 2003,362 : 759 - 766.
  • 10Hansson L, Hedner T,Dahlof B. Prospective randomized open blinded end - point (PROBE) study. A novel design for intervention trials[J]. Blood Press,1992,1:113 - 119.

共引文献77

同被引文献34

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部